Accumulation of Quinolinic Acid With Neuroinflammation: Does It Mean Excitotoxicity?
Part of the
Advances in Experimental Medicine and Biology
book series (AEMB, volume 527)
The quinolinic acid (QUIN) accumulation that is associated with neuroinflammation is often considered capable of promoting excitotoxic neuronal damage, but QUIN is a relatively weak agonist of N-methyl-D-aspartate (NMDA) receptors. Our study aimed to determinein vivowhich extracellular concentrations of QUIN must be reached to initiate electrophysiological changes indicative of excitotoxic stress in the cerebral cortex of rats, under normal conditions and when superimposed to a challenge involving NMDA-receptor activation, i.e. repeated cortical spreading depression (CSD). Our experimental strategy relied on microdialysis probes incorporating an electrode, implanted in the brain of halothane-anaesthetised rats. These devices were used to apply QUIN or NMDA locally to the cortical area under study (with or without co-perfusion of high K’ for repetitive induction of CSD), and to record the associated changes in the extracellular DC potential (for information on the membrane polarisation of the cellular population surrounding the probe) and lactate (for the detection of increased local energy demand).
The extracellular EC50for induction of local depolarisation in the normal cortex was around 30 times higher than the extracellular QUIN levels measured in the immunoactivated brain of gerbils. Within the range of concentrations 0.03 to 0.3 mM in the perfusion medium, QUIN suppressed concentration-dependently the elicitation of CSD by K’, presumably because of NMDA-receptor desensitisation. Finally, on-line monitoring of changes in extracellular lactate with local application of QUIN indicated that extracellular concentration of QUIN in the low micromolar range are well tolerated by the brain parenchyma, at least in cortical regions. All these data do not support the notion that QUIN accumulation adds an excitotoxic component to neuroinflammation.
the kynurenine pathway in invading macrophages and activated microglia;1’3’4(ii) QUIN is an agonist of N-methylD-aspartate (NMDA) receptors.5’6However, QUIN is a relatively weak agonist of NMDA-receptors,’ and millimolar concentrations of this excitotoxin had to be microinjected in the striatum of rats to cause acute neurodegeneration.5’6
Ourin vivostudies had two complementary objectives: (i) To determine which extracellular concentrations of QUIN must be reached to initiate electrophysiological changes indicative of excitotoxic stress in the cerebral cortex of rats under normal conditions; and (ii) to examine how increased extracellular concentrations of QUIN alter a well-characterised phenomenon that involves glutamate/NMDA-receptor-mediated synaptic transmission, i.e. cortical spreading depression (CSD).
KeywordsToxicity Ischemia Lactate Dementia Glycine
M.P. Heyes, The kynurenine pathway and neurologic disease. Therapeutic strategiesAdv. Exp. Med. Biol.
398,125–129 (1996).PubMedCrossRefGoogle Scholar
G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protectionJ. Neurochem.
78, 842–853 (2001).PubMedCrossRefGoogle Scholar
D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Köhler, A.M. Cesura, Regulation of the kynurenine metabolic pathway by interferon-y in murine cloned macrophages and microglial cellsJ. Neurochem.
996–1004 (1996).PubMedCrossRefGoogle Scholar
G.J. Guillemin, S.J. Kerr, L.A. Pemberton, D.G. Smith, G.A. Smythe, P.J. Armati, J. Croitoru, B.J. Brew, lFN-01b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatmentJ. Interferon Cytokine Res.
1097–1101 (2001).PubMedCrossRefGoogle Scholar
R. Schwarcz, W.O. Jr. Whetsell, R.M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brainScience
316–318 (1983).PubMedCrossRefGoogle Scholar
M. Levivier, S. Przedborski, Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessmentNeurol. Res.
46–56 (1998).PubMedGoogle Scholar
M.C. Curras, R. Dingledine, Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3hydroxy-5-methyl-isoxazoleproprionate receptorsMo!. Pharmacol.
520–526 (1992).Google Scholar
T.P. Obrenovitch, D.A. Richards, G.S. Sama, L. Symon, Combined intracerebral microdialysis and electrophysiological recording: Methodology and applicationsJ. Neurosci. Meth.
139–145 (1993).CrossRefGoogle Scholar
T.P. Obrenovitch J. Urenjak, E. Zilkha Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugsin vivo
Br. J. Pharmacol.
113 1295–1302 (1994).PubMedCrossRefGoogle Scholar
T.P. Obrenovitch, J. Urenjak, E. Zilkha. Intracerebral microdialysis combinedwith
recording of extracellular field potential: a novel method for investigation of depolarizing drugsin vivo
Br. J. Pharmacol.
1295–1302 (1994).PubMedCrossRefGoogle Scholar
R. Exley, E. Zilkha, J. Urenjak, T.P. Obrenovitch, Continuous monitoring of changes in brain extracellular lactate using microdialysis coupled to enzyme-amperometric analysisBr. J. Pharmacol.
219 (2000).Google Scholar
K.E. Beagles, P.F. Morrison, M.P. Heyes, Quinolinicacid in vivo
synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysisJ. Neurochem.
281–291 (1998).PubMedCrossRefGoogle Scholar
M. Minervini, A. Atlante, S. Gagliardi, M.T. Ciotti, E. Marra, P. Calissano, Glutamate stimulates 2deoxyglucose uptake in rat cerebellar granule cellsBrain Res.
57–62 (1997).PubMedCrossRefGoogle Scholar
Y.M. Bordelon, M.-F. Chesselet, M. Erecinska, I.A. Silver, EtTects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatumin vivo
459–469 (1998).PubMedCrossRefGoogle Scholar
M. Demestre, M. Boutelle, M. Fillenz, Stimulated release of lactate in freely moving rats is dependent on the uptake of glutamateJ. Physiol.
825–832 (1997)PubMedGoogle Scholar
A.E. Fray, R.J. Forsyth, M.G. Boutelle, M. Fillenz, The mechanisms controlling physiologically stimulated changes in rat brain glucose and lactate: a microdialysis studyJ. Physiol.
49–57 (1996).PubMedGoogle Scholar
T.P. Obrenovitch TP, E. Zilkha, Microdialysis coupled to online enzymatic assaysMethods
63–71 (2001).PubMedCrossRefGoogle Scholar
T.P. Obrenovitch, E. Zilkha, Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complexBr. J. Pharmacol.
931–937 (1996).PubMedCrossRefGoogle Scholar
F.S. Menniti, M.J. Pagnozzi, P. Butler, B.L. Chenard, S.S. Jaw-Tsai, W. Frost, White CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodentsNeuropharmacology
1147–1155 (2000).PubMedCrossRefGoogle Scholar
T.P. Obrenovitch, E. Zilkha, J. Urenja, Evidence against high extracellular glutamate promoting the elicitation of spreading depression by potassiumJ. Cereb. Blood Flow Melab.
16,923–93 I (1996).CrossRefGoogle Scholar
W.O. Whetsell, R. Schwarcz, Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal systemNeurosci. Lett
271–275 (1989).PubMedCrossRefGoogle Scholar
S.J. Kerr, P.J. Armati, G.J. Guillemin, B.J. Brew, Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex.AIDS
3555–363 (1998).CrossRefGoogle Scholar
R. Balazs, N. Hack, O.S. Jorgensen, C.W. Cotman, N-methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological considerationsNeurosci. Lett.
242–246 (1989).CrossRefGoogle Scholar
D.M. Chuang, X.M. Gao, S.M. Paul, N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cellsMol. Pharmacol.
210–216 (1992).PubMedGoogle Scholar
N.J. Pantazis, D.P. Dohrman, J. Luo, J.D. Thomas, C.R. Goodlett, J.R. West, NMDA prevents alcohol-induced neuronal cell death of cerebellar granule cells in cultureAlcohol Clin. Exp. Res
846–853 (1995).PubMedCrossRefGoogle Scholar
A.M. Marini, Y. Ueda, C.H. June, Intracellular survival pathways against glutamate receptor agonist excitotoxicity in cultured neurons. Intracellular calcium responsesAnn. N.Y. Acad. Sci.
421–437 (1999).PubMedCrossRefGoogle Scholar
A.M. Marini, S.J. Rabin, R.H. Lipsky, I. Mocchetti, Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartateJ. Biol. Chem.
29394–29399 (1998).PubMedCrossRefGoogle Scholar
Y. Sei, L. Fossom, G. Gaping, P. Skolnick, A.S. Basile, Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosisNeurosci. Lett.
180–184 (1998).PubMedCrossRefGoogle Scholar
Z.H. Qin, R.W. Chen, Y. Wang, M. Nakai, D.M. Chuang, T.N. Chase, Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatumJ. Neurosci.
4023–4033 (1999).PubMedGoogle Scholar
W.M. Behan, M. McDonald, L.G. Darlington, T.W. Stone, Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenylBr. J. Pharmacol
1754–1760 (1999).CrossRefGoogle Scholar
T.W. Stone. Endogenous neurotoxins from tryptophanToxicon.
61–73 (2001).PubMedCrossRefGoogle Scholar
H. Lehnert, R.J. Wurtman, Amino acid control of neurotransmitter synthesis and release: physiological and clinical implicationsPsychother. Psychosom.
18–32 (1993).PubMedCrossRefGoogle Scholar
F.A. Moreno, C. McGavin, T.P. Malan, A.J. Gelenberg, G.R. Heninger, A.A. Mathe, P.L. Delgado, Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: results from single lumbar puncture sampling techniqueInt. J. Neuropsychopharmacol.
277–283 (2000).PubMedCrossRefGoogle Scholar
C. Bell, J. Abrams, D. Nutt, Tryptophan depletion and its implications for psychiatryBr. J. Psychiatry
399–405 (2001).PubMedCrossRefGoogle Scholar
© Springer Science+Business Media New York 2003